HeartCore Enterprises, Inc. Form 8-K Summary
Reporting date: April 4, 2023 earliest reported event; the filing was signed and filed April 11, 2023. HeartCore Enterprises, Inc. is a Delaware corporation headquartered in Tokyo, Japan, with common stock trading on Nasdaq under HTCR.
Business Context and Material Agreement
On April 4, 2023, HeartCore entered into an eight-month Consulting and Services Agreement with RYojbaba Inc., a Japanese corporation. HeartCore will provide support related to a potential initial public offering, de-SPAC transaction, or other fundamental transaction involving RYojbaba.
- Services include assistance with selecting legal, underwriting, and auditing firms; internal-control documentation; accounting-data conversion from Japanese standards to U.S. GAAP; SEC filing support; Nasdaq listing support; translation; management meetings; and preparation of investor materials.
- HeartCore will not provide legal or accounting services, act as an investment adviser or broker-dealer, negotiate securities sales, participate in investor discussions, perform due diligence, or advise on valuation or investment advisability.
Consideration and Warrant
- RYojbaba will pay HeartCore $500,000: $200,000 on April 4, 2023; $150,000 on the three-month anniversary; and $150,000 when RYojbaba first files a specified SEC registration or similar form relating to a qualifying transaction.
- RYojbaba issued HeartCore a warrant, deemed fully earned and vested on April 4, 2023, initially intended to represent 3% of RYojbaba’s fully diluted share capital.
- The warrant is exercisable following a qualifying U.S. IPO, SPAC transaction, or other fundamental transaction, and generally remains exercisable through the tenth anniversary of the trigger date.
- The warrant initially covers 3,000 RYojbaba common shares at an exercise price of $0.01 per share, subject to adjustment to 3% of RYojbaba’s fully diluted shares and other provisions in the warrant.
- The warrant contains a 9.99% equity blocker. Services performed after the agreement term are billable at $150 per hour.
Financial Metrics and Liquidity
This Form 8-K does not provide revenue, profit, cash flow, margin, debt, liquidity, balance-sheet, or other operating metrics for HeartCore. It also does not quantify the accounting treatment or fair value of the warrant or the timing of recognition of the $500,000 fee.
Changes, Outlook, Risks, and Unusual Items
- The material change disclosed is HeartCore’s entry into the RYojbaba consulting arrangement and receipt of the contingent equity warrant.
- The agreement may be terminated by either party upon notice, and the final $150,000 payment is contingent on a future RYojbaba SEC filing.
- The warrant’s value and ultimate exercisability depend on RYojbaba completing a qualifying transaction and meeting the applicable trigger conditions. No assurance is provided that such a transaction will occur.
- The warrant is subject to adjustment provisions and a 9.99% ownership limitation, which may affect the number of shares exercisable at a given time.
- The filing includes an April 11, 2023 press release under Regulation FD; the filing states that this information is not deemed filed for purposes of Exchange Act Section 18 or incorporated by reference except as expressly stated.
Investor Verification Items
- Verify the executed Consulting and Services Agreement and the payment schedule, including whether the initial $200,000 was received.
- Review the warrant’s adjustment mechanics, trigger conditions, expiration provisions, and 9.99% equity blocker.
- Confirm the accounting treatment, valuation, and potential dilution associated with the warrant.
- Assess whether RYojbaba completes an IPO, SPAC transaction, or other qualifying transaction and whether the contingent $150,000 payment becomes due.
- Review subsequent SEC filings for revenue recognition, related-party considerations, contract termination, and changes in the warrant’s share entitlement.